National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English     En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 14  :  A "Clinical Match" <  >  

An ideal 6:6 antigen match, known as a "clinical match," means that both sets of the three "most important" inherited human leukocyte antigens in the donor match perfectly with those on the body (and immune) cells in the patient. Below, only Child E would serve as a 6:6 clinically matched donor for Child A; one sibling is a total mismatch; the other siblings and both parents would be haplo-identical because only one of their two inherited haplotypes matches Child A.

A 'Clinical Match'

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov